(Q41333546)

29 September 2017

1 reference

title

Arthritis syndromes associated with human T cell lymphotropic virus type I infection (English)

1 reference

Human T-lymphotropic virus 1

29 September 2017

0 references

4

Haynes BF

1 reference

29 September 2017

McCallum RM

1

1 reference

PubMed ID

9012764

29 September 2017

Patel DD

series ordinal

2

1 reference

PubMed ID

9012764

29 September 2017

Moore JO

series ordinal

3

1 reference

29 September 2017

1 January 1997

1 reference

Medical Clinics of North America

29 September 2017

1 reference

29 September 2017

81

1 reference

29 September 2017

1

1 reference

29 September 2017

261-276

1 reference

Treatment of patients with polyarthritis and anti-HTLV-I antibodies with interferon-alpha

29 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970514-9

Immunoglobulin G antibodies binding to a synthetic peptide deduced from the nucleotide sequence of the env gene of HTLV I in patients with leukemia and rheumatoid arthritis, HLA sensitized persons and blood donors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970514-9

Deoxycoformycin in the treatment of mature T-cell leukaemias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970514-9

Absence of lentiviral and human T cell leukemia viral sequences in patients with rheumatoid arthritis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970514-9

Primary Sjögren's syndrome with antibodies to HTLV-I: clinical and laboratory features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970514-9

HTLV-I associated arthritis: characteristics of an HTLV-I virus infected T cell line from synovial fluid.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970514-9

High seroprevalence of anti-HTLV-I antibody in rheumatoid arthritis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970514-9

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970514-9

A combination trial of human lymphoblastoid interferon and bestrabucil (KM2210) for adult T-cell leukemia–lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970514-9

New evidence for involvement of retroviruses in Sjögren's syndrome and other autoimmune diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970514-9

Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970514-9

Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970514-9

Exocrinopathy resembling Sjögren's syndrome in HTLV-1 tax transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970514-9

Leukemia-associated arthritis: identification of leukemic cells in synovial fluid using monoclonal and polyclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970514-9

Identification of human T cell leukemia virus in a Japanese patient with adult T cell leukemia and cutaneous lymphomatous vasculitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970514-9

Treatment of Adult T-Cell Leukemia-Lymphoma with Zidovudine and Interferon Alfa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970514-9

Effective treatment of adult T cell leukemia/lymphoma with a novel oral antitumor agent, MST-16

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970514-9

Arthritis in a human T lymphotropic virus type I (HTLV-I) carrier

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970514-9

Induction of inflammatory arthropathy resembling rheumatoid arthritis in mice transgenic for HTLV-I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970514-9

Polyarthritis in human T lymphotropic virus type I-associated myelopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970514-9

Successful treatment of a patient with adult T-cell leukemia by daily oral administration of low-dose etoposide. Decrease in the amount of HTLV-I proviral DNA revealed by the polymerase chain reaction method.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970514-9

New horizons in HTLV-I and HTLV-II diagnosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970514-9

No association between antibodies to HTLV-1 and polymyositis, rheumatoid arthritis and SLE.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970514-9

Antibodies to HTLV-I in Sjögren's syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970514-9

The role of interleukin–15 in T–cell migration and activation in rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970514-9

Successful treatment of adult T-cell leukemia/lymphoma with MACOP-B, M-FEPA and VEPP-B combination chemotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970514-9

Overgrowth of human synovial cells driven by the human T cell leukemia virus type I tax gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970514-9

Chronic inflammatory arthropathy associated with HTLV-I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970514-9

Infection of human synovial cells by human T cell lymphotropic virus type I. Proliferation and granulocyte/macrophage colony-stimulating factor production by synovial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970514-9

Arthritis in patients infected with human T lymphotropic virus type I. Clinical and immunopathologic features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970514-9

Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970514-9

The arthritis of leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970514-9

Expression of sequences homologous to HTLV-I tax gene in the labial salivary glands of Japanese patients with Sjögren's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970514-9

Detection of serum antibodies to retroviral proteins in patients with primary Sjögren's syndrome (autoimmune exocrinopathy)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970514-9

Recombinant interferon beta and gamma in the treatment of adult T-cell leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970514-9

Adult T cell leukemia presenting with proliferative synovitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970514-9

Prevalence of serum and salivary antibodies to HTLV-1 in Sjögren's syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970514-9

Interleukin-1 receptor antagonist (IL-1ra) as a probe and as a treatment for IL-1 mediated disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970514-9

Characteristics of chemotherapy-induced clinical remission in long survivors with aggressive adult T-cell leukemia/lymphoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970514-9

Interleukin-2 receptor (Tac antigen) expressed on adult T cell leukemia cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970514-9

Adhesion properties of adult T cell leukemia cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970514-9

Lymphokine receptors: a target for immunotherapy of lymphomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970514-9

Functional and phenotypic comparison of human T cell leukemia/lymphoma virus positive adult T cell leukemia with human T cell leukemia/lymphoma virus negative Sézary leukemia, and their distinction using anti-Tac. Monoclonal antibody identifying the

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970514-9

Interleukin 1 gene expression in adult T cell leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970514-9

Inflammatory polyarthritis in mice transgenic for human T cell leukemia virus type I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970514-9

HTLV-I-associated adult T-cell leukemia/lymphoma presenting with nodular synovial masses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970514-9

Diseases associated with HTLV-I: virus, IL-2 receptor dysregulation and redox regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970514-9

10.1016/S0025-7125(05)70514-9

7 January 2021

Identifiers

DOI

1 reference

29 September 2017

1 reference

PubMed ID

9012764